BLLN vs SHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SHC Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sotera Health Company Common Stock (SHC) driven by superior Valuation, Growth & Margin, Options & Structure while BLLN counters with relative strength in Momentum & Technical. Fundamentally, BLLN trades at 61.3x Forward P/E with 10.2% operating margin (+47.2% YoY revenue) versus SHC at 15.3x Forward P/E and 36.8% operating margin (+4.4% YoY). In options structure, BLLN sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against SHC sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BLLN | SHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.0B | $4.7B | Larger Scale | BLLN |
| Trailing P/E Ratio Valuation | 114.3x | 27.7x | Lower Multiple | SHC |
| Forward P/E Ratio Valuation | 61.3x | 15.3x | Lower Multiple | SHC |
| Revenue Growth (YoY) Growth | +47.2% | +4.4% | Higher Growth | BLLN |
| Operating Margin (TTM) Profitability | 10.2% | 36.8% | Higher Margin | SHC |
| Net Profit Margin Profitability | 10.5% | 14.1% | Higher Margin | SHC |
| Return on Equity (ROE) Capital Efficiency | 13.2% | 27.0% | Higher ROE | SHC |
| 52-Week Range Position Momentum | 39% ($62โ$150) | 47% ($13โ$20) | Stronger Trend | SHC |
| Beta / 30D Volatility Risk Regime | 1.44ฮฒ ยท 42% Vol | 0.95ฮฒ ยท 44% Vol | Lower Realized Risk | BLLN |
| Unified Institutional Score Composite Signal | 45.8 / 100 (HOLD) | 63.1 / 100 (BUY) | Higher Composite | SHC |